E. Liakopoulou

发表

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin’s lymphoma: identification of prognostic factors predicting outcome

N. Schmitz, A. Pettitt, N. Russell, 2009, Haematologica.

Hematopoietic stem cell transplantation in qatar: One-year anniversary.

A. Knuth, S. Dermime, R. Taha, 2017, Hematology/oncology and stem cell therapy.

Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry.

G. Morgan, N. Russell, F. Davies, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Laboratory Features of Hospitalised Patients with COVID-19 in Jersey, UK

S. Gama, E. Liakopoulou, Julia Bellamy, 2022, EJIFCC.

Donor cell leukemia following unrelated donor bone marrow transplantation for primary granulocytic sarcoma of the small intestine

K. Poulton, D. Wiseman, E. Liakopoulou, 2011, American journal of hematology.

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

H. Einsele, C. Heussel, P. Ljungman, 2010, Haematologica.

Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation

J. Cornish, N. Goulden, D. Marks, 2005, Bone Marrow Transplantation.

Stimulation of fetal hemoglobin production by short chain fatty acids.

G. Stamatoyannopoulos, Qiliang Li, Q. Li, 1995, Blood.

Fetal hemoglobin induction by acetate, a product of butyrate catabolism.

B. Pace, G. Stamatoyannopoulos, S. Brusilow, 1994, Blood.

Induction of fetal hemoglobin by propionic and butyric acid derivatives: correlations between chemical structure and potency of Hb F induction.

G. Stamatoyannopoulos, Qiliang Li, E. Liakopoulou, 2002, Blood Cells, Molecules & Diseases.

Precision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality?

A. Knuth, E. Liakopoulou, 2015, Visceral Medicine.

Can we deconstruct cancer, one patient at a time?

E. Liakopoulou, C. Blau, C. Anthony Blau, 2013, Trends in genetics : TIG.

Serum Free Light Chain (SFLC) Concentration Kinetics in Patients Receiving Bortezomib: Temporary Inhibition of Protein Synthesis and Early Biomarker for Disease Response.

G. Mead, J. Cavet, Julia A. M. Anderson, 2005 .

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

C. Craddock, N. Russell, R. Clark, 2009, Haematologica.

The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma

B. Kahan, J. Moppett, S. Stanworth, 2012, Transfusion medicine.

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia

P. Vyas, C. Craddock, S. Nagra, 2010, Haematologica.

C. Craddock, N. Russell, J. Byrne, 2011, British journal of haematology.

Introduction to haematopoietic stem cell transplantation

D. Marks, E. Liakopoulou, 2008 .

HLA-DR15, reduced relapse rate and improved survival after HLA identical sibling hemopoietic stem cell transplantation.

K. Poulton, R. Wynn, G. Lucas, 2007, Biology of Blood and Marrow Transplantation.

Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia

E. Allan, A. Eaves, C. Eaves, 2003, Leukemia.

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced‐intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

J. Burthem, C. Craddock, E. Tholouli, 2008, British journal of haematology.